Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xencor Inc (NQ: XNCR ) 20.84 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Xencor Inc < Previous 1 2 3 Next > Xencor to Present Data from the Phase 1 Study of Vudalimab (XmAb®717) and Four Research Programs at the SITC Annual Meeting October 01, 2021 From Xencor, Inc. Via Business Wire Xencor to Present at the 2021 Cantor Virtual Global Healthcare Conference September 20, 2021 From Xencor, Inc. Via Business Wire Xencor Reports Second Quarter 2021 Financial Results August 04, 2021 From Xencor, Inc. Via Business Wire Xencor to Present at Upcoming Investor Conferences August 02, 2021 From Xencor, Inc. Via Business Wire Xencor to Host Second Quarter 2021 Financial Results Webcast and Conference Call on August 4, 2021 July 28, 2021 From Xencor, Inc. Via Business Wire Xencor to Present at the Jefferies Virtual Healthcare Conference May 27, 2021 From Xencor, Inc. Via Business Wire Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19 May 26, 2021 From Xencor, Inc. Via Business Wire Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19 May 25, 2021 From Xencor, Inc. Via Business Wire Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference May 12, 2021 From Xencor, Inc. Via Business Wire Xencor Reports First Quarter 2021 Financial Results May 05, 2021 From Xencor, Inc. Via Business Wire Xencor Doses First Subject in Phase 1 Study of XmAb®564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases April 28, 2021 From Xencor, Inc. Via Business Wire Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021 April 28, 2021 From Xencor, Inc. Via Business Wire Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021 April 10, 2021 From Xencor, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.